Stock Report

All about this stock under one free report Last Updated: 29-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Hemo Organic Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 524590

₹18.91

up-down-arrow ₹-0.99 (-4.97%)

As on 24-Aug-2026IST

Market cap

info icon

₹7 Cr

Revenue (TTM)

info icon

₹1 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

-6.5

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -61.63 470.21 158.70
EBIT 75.08 35.09 -255.81 -292.31 -247.58
Net Profit 85.38 12.94 -698.44 -330.53 -267.08
EPS 85.38 12.93 -698.27 -282.34 -267.09
Book Value -- -- -513.61 -352.82 -269.82
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info -381.49-638.11-49.51-53.46-1.73
Net Margin info -415.19-415.19-82.45-83.586.60
Return on equity info 0.00-36.03--0.000.00
Return on Capital info -24.95-129.80---23.542.51
Return on Assets info -19.34-31.86-16.23-16.995.83
Debt to Equity (x) info ----20.77-2.95-9.77

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
--
-23.54
2.51
-53.80
-484.90
Peer Median
--
16.69
14.23
13.72
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
--
--
--
--
--
Peer Median
3.61
13.78
9.34
9.55
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-16.23

Lower than Peers by 18.97

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
-16.23
-16.99
5.83
-46.85
-36.11
Peer Median
2.74
9.65
5.46
5.81
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-49.51

Lower than Peers by 52.72

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
-49.51
-53.46
-1.73
-1,089.29
-1,135.42
Peer Median
3.21
21.68
--
12.51
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-82.45

Lower than Peers by 84.61

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
-82.45
-83.58
6.60
-1,168.58
-1,137.50
Peer Median
2.16
7.13
3.10
3.56
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
--
-83.69
6.79
-1,179.02
-1,137.50
Peer Median
--
0.00
--
0.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-61.63

Lower than Peers by 74.74

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
-61.63
-61.52
--
366.67
-29.72
Peer Median
13.11
59.91
--
38.08
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-255.81

Lower than Peers by 256.18

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
-255.81
-1,090.89
82.91
-347.71
12.38
Peer Median
0.36
58.30
--
460.14
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-698.44

Lower than Peers by 696.00

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
-698.44
-574.74
162.06
-383.70
12.46
Peer Median
-2.44
57.78
--
-3.95
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-698.27

--

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
-698.27
-574.73
162.06
-383.81
12.45
Peer Median
--
11.46
--
90.91
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
--
-513.60
51.97
-516.02
-1,590.97
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

20.77

--

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
20.77
-2.95
-9.77
-3.92
-0.69
Peer Median
--
0.04
0.04
0.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

2.81

Higher than Peers by 0.79

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
2.81
2.81
1.29
6.50
0.56
Peer Median
2.02
2.56
2.10
2.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.49

Higher than Peers by 1.26

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
2.49
2.49
0.90
6.50
0.52
Peer Median
1.23
2.33
--
3.80
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
--
-133.68
10.85
-12.01
-545.00
Peer Median
7.68
34.74
16.23
8.29
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

257.71

Higher than Peers by 242.47

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
257.71
257.12
104.27
369.20
1,233.33
Peer Median
15.24
16.30
--
27.50
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.20

Lower than Peers by 1.04

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
0.20
0.20
0.86
0.04
0.03
Peer Median
1.24
2.28
--
1.26
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
--
963.79
196.55
1,156.10
4,500.64
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
--
378.08
214.12
--
1,223.62
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
--
1,020.02
310.20
2,538.30
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
--
321.86
100.48
-1,382.20
5,724.26
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
--
--
18.97
--
--
Peer Median
20.84
20.33
30.84
47.94
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

-6.53

Lower than Peers by 7.57

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
-6.53
-4.36
-20.52
-11.21
-48.06
Peer Median
1.04
2.72
6.38
4.56
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
--
--
--
--
--
Peer Median
--
0.25
--
0.08
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-20.31

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
-20.31
-13.73
162.40
-19.05
-43.66
Peer Median
--
14.82
30.04
35.83
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

7

Lower than Peers by 62

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Hemo Organic
7
4
3
4
2
Peer Median
69
199
268
133
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...